CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres
by Suzhou Hengrui Callisyn Biomedical Co., Ltd.
510(k) K173871
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK173871 | Date17 Sep 2018 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NAJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.3300
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
CalliSpheres Embolic Microspheres and 8Spheres Embolic Microspheres are embolic agents indicated for the treatment of uterine fibroids. These devices are designed to function as embolic agents within the cardiovascular system.
This device is identified under FDA 510(k) number K173871. It is classified as a class 2 medical device under regulation number 870.3300.
Questions
AI-generated answers, 22 Sep 2026
What are CalliSpheres and 8Spheres Embolic Microspheres used for?
These devices are indicated for the treatment of uterine fibroids. They function as embolic agents designed for use within the cardiovascular system.
What is the regulatory status of these embolic microspheres?
These devices are identified under FDA 510(k) number K173871. They are classified as class 2 medical devices under regulation number 870.3300.
Who is the manufacturer of these embolic agents?
CalliSpheres and 8Spheres Embolic Microspheres are manufactured by Suzhou Hengrui Callisyn Biomedical Co., Ltd., located in Suzhou, China.